Clinical Trial Update: Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

View source ↗

Summary

Recruitment is underway for a study to identify predictive biomarkers of pneumonitis risk in non-small cell lung cancer patients treated with chemoradiotherapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Non-Small Cell Carcinoma | Status: RECRUITING